What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines?
Despite considerable improvements in medical care over the past 25 years, cardiovascular disease (CVD) remains a major public health challenge. Dyslipidemias are one of the topics of greatest interest in cardiology. Decreasing serum cholesterol level is a central objective for preventing cardiovascu...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Balkan Medical Union
2019-12-01
|
| Series: | Archives of the Balkan Medical Union |
| Subjects: | |
| Online Access: | https://umbalk.org/wp-content/uploads/2019/11/21.WHAT-IS-NEW-REGARDING-THE-TREATMENT.pdf |
| _version_ | 1818041584564830208 |
|---|---|
| author | Madalina A. MUNTEANU Gina GHEORGHE Ana Maria A. STANESCU Ovidiu G. BRATU Camelia C. DIACONU |
| author_facet | Madalina A. MUNTEANU Gina GHEORGHE Ana Maria A. STANESCU Ovidiu G. BRATU Camelia C. DIACONU |
| author_sort | Madalina A. MUNTEANU |
| collection | DOAJ |
| description | Despite considerable improvements in medical care over the past 25 years, cardiovascular disease (CVD) remains a major public health challenge. Dyslipidemias are one of the topics of greatest interest in cardiology. Decreasing serum cholesterol level is a central objective for preventing cardiovascular events. The current European Society of Cardiology guidelines recommend evaluation of the cardiovascular risk, treatment decisions being based on this risk, and clinician–patient discussion about the risk (shared decision making). |
| first_indexed | 2024-12-10T08:32:45Z |
| format | Article |
| id | doaj.art-a74223be16054f9aa3f489219320ab85 |
| institution | Directory Open Access Journal |
| issn | 1584-9244 2558-815X |
| language | English |
| last_indexed | 2024-12-10T08:32:45Z |
| publishDate | 2019-12-01 |
| publisher | Balkan Medical Union |
| record_format | Article |
| series | Archives of the Balkan Medical Union |
| spelling | doaj.art-a74223be16054f9aa3f489219320ab852022-12-22T01:56:03ZengBalkan Medical UnionArchives of the Balkan Medical Union1584-92442558-815X2019-12-0154474975210.31688/ABMU.2019.54.4.21What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines?Madalina A. MUNTEANU Gina GHEORGHEAna Maria A. STANESCUOvidiu G. BRATUCamelia C. DIACONUDespite considerable improvements in medical care over the past 25 years, cardiovascular disease (CVD) remains a major public health challenge. Dyslipidemias are one of the topics of greatest interest in cardiology. Decreasing serum cholesterol level is a central objective for preventing cardiovascular events. The current European Society of Cardiology guidelines recommend evaluation of the cardiovascular risk, treatment decisions being based on this risk, and clinician–patient discussion about the risk (shared decision making).https://umbalk.org/wp-content/uploads/2019/11/21.WHAT-IS-NEW-REGARDING-THE-TREATMENT.pdfatherosclerosiscardiovascular riskdyslipidemialdl-cholesteroltriglycerides |
| spellingShingle | Madalina A. MUNTEANU Gina GHEORGHE Ana Maria A. STANESCU Ovidiu G. BRATU Camelia C. DIACONU What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines? Archives of the Balkan Medical Union atherosclerosis cardiovascular risk dyslipidemia ldl-cholesterol triglycerides |
| title | What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines? |
| title_full | What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines? |
| title_fullStr | What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines? |
| title_full_unstemmed | What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines? |
| title_short | What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines? |
| title_sort | what is new regarding the treatment of dyslipidemia in the 2019 european society of cardiology guidelines |
| topic | atherosclerosis cardiovascular risk dyslipidemia ldl-cholesterol triglycerides |
| url | https://umbalk.org/wp-content/uploads/2019/11/21.WHAT-IS-NEW-REGARDING-THE-TREATMENT.pdf |
| work_keys_str_mv | AT madalinaamunteanu whatisnewregardingthetreatmentofdyslipidemiainthe2019europeansocietyofcardiologyguidelines AT ginagheorghe whatisnewregardingthetreatmentofdyslipidemiainthe2019europeansocietyofcardiologyguidelines AT anamariaastanescu whatisnewregardingthetreatmentofdyslipidemiainthe2019europeansocietyofcardiologyguidelines AT ovidiugbratu whatisnewregardingthetreatmentofdyslipidemiainthe2019europeansocietyofcardiologyguidelines AT cameliacdiaconu whatisnewregardingthetreatmentofdyslipidemiainthe2019europeansocietyofcardiologyguidelines |